Dual Targeting of Insulin and Venus Kinase Receptors of Schistosoma mansoni for Novel Anti-schistosome Therapy

BACKGROUND: Chemotherapy of schistosomiasis relies on a single drug, Praziquantel (PZQ) and mass-use of this compound has led to emergence of resistant strains of Schistosoma mansoni, therefore pointing out the necessity to find alternative drugs. Through their essential functions in development and...

Descripción completa

Detalles Bibliográficos
Autores principales: Vanderstraete, Mathieu, Gouignard, Nadège, Cailliau, Katia, Morel, Marion, Lancelot, Julien, Bodart, Jean-François, Dissous, Colette
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656120/
https://www.ncbi.nlm.nih.gov/pubmed/23696913
http://dx.doi.org/10.1371/journal.pntd.0002226

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3656120/
https://www.ncbi.nlm.nih.gov/pubmed/23696913
http://dx.doi.org/10.1371/journal.pntd.0002226

Ejemplares similares